000 | 01349 a2200433 4500 | ||
---|---|---|---|
005 | 20250512221048.0 | ||
264 | 0 | _c19840620 | |
008 | 198406s 0 0 eng d | ||
022 | _a0161-813X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGraham, D G | |
245 | 0 | 0 |
_aCatecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. _h[electronic resource] |
260 |
_bNeurotoxicology _c1984 |
||
300 |
_a83-95 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAging |
650 | 0 | 4 |
_aCatecholamines _xmetabolism |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDNA Polymerase II _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aManganese Poisoning |
650 | 0 | 4 |
_aMelanins _xmetabolism |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNervous System Diseases _xchemically induced |
650 | 0 | 4 |
_aNeuroblastoma _xmetabolism |
650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aParkinson Disease _xetiology |
650 | 0 | 4 |
_aQuinones _xmetabolism |
650 | 0 | 4 |
_aSulfhydryl Compounds _xmetabolism |
650 | 0 | 4 |
_aThymidine _xmetabolism |
650 | 0 | 4 |
_aThymus Gland _xmetabolism |
773 | 0 |
_tNeurotoxicology _gvol. 5 _gno. 1 _gp. 83-95 |
|
999 |
_c6538821 _d6538821 |